Versant Ventures VI GP, L.P.
10% owner at Monte Rosa Therapeutics; 10% owner at LENZ Therapeutics.
- Rank
- 738th of 813
- Companies held
- 2
- Largest holding
- GLUE, 89.4% of total
- Latest SEC filing
- Jun 20, 2025
- Listed but not counted
- $25.0M
What the $62.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics GLUE Common Stock | Directly | 6,231,902 | $8.91 | $55.5M | 89.4% | Form 4, Sep 13, 2024 |
| LENZ Therapeutics LENZ Common Stock | Directly | 1,967,275 | $3.34 | $6.6M | 10.6% | Form 4, Jun 20, 2025 |
Share counts are the amounts Versant Ventures VI GP, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Versant Ventures VI GP, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics GLUE Common Stock | Through Versant Vantage I, L.P. Held by a company or fund the insider manages | 2,097,938 | $8.91 | $18.7M | — | Form 4, Sep 11, 2024 |
| LENZ Therapeutics LENZ Common Stock | Through Versant Venture Capital VII, L.P. Held by a company or fund the insider manages | 1,047,912 | $3.34 | $3.5M | — | Form 4, Jun 20, 2025 |
| LENZ Therapeutics LENZ Common Stock | Through Versant Vantage II, L.P. Held by a company or fund the insider manages | 842,162 | $3.34 | $2.8M | — | Form 4, Jun 18, 2025 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 735 | AH Equity Partners V (Parallel), L.L.C. 10% owner, Samsara | $63.3M |
| 736 | MiTAC International CORP Insider, Concentrix | $63.1M |
| 737 | Bitmine Immersion Technologies, Inc. 10% owner, Eightco Holdings | $62.9M |
| 738 | Versant Ventures VI GP, L.P. 10% owner, Monte Rosa Therapeutics | $62.1M |
| 739 | IRHO SPAC Sponsor LLC 10% owner, Iron Horse Acquisitions Corp. II | $62.0M |
| 740 | Viking Cake Fuel, LLC 10% owner, Black Rock Coffee Bar | $61.5M |
| 741 | Dimension Capital II, L.P. Director, Odyssey Therapeutics | $61.1M |
Other Monte Rosa Therapeutics insiders
All GLUE insiders- Markus Warmuth$5.2MPresident & CEO. #14039 overall
Questions
How much stock does Versant Ventures VI GP, L.P. own?
Versant Ventures VI GP, L.P. holds $62,096,945 in listed stock based on SEC filings and current prices, mostly Monte Rosa Therapeutics (GLUE). That ranks 738th on the Stock Rich List.
Is this Versant Ventures VI GP, L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.